Recent data have shown that the JAK2/STAT3 pathway is preferentially activated in CD44 + CD24- breast CSCs through the excessive production of IL6 and promotes CSC growth in breast tumors [27]. The gene discussed is JAK2; the disease is breast neoplasm.